Brn-3a neuronal transcription factor functional expression in human prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 1, 2006, Pages 83-91

  Diss, J K J ^a   Faulkes, D J ^a   Walker, M M ^b   Patel, A ^b   Foster, C S ^c   Budhram Mahadeo, V ^a   Djamgoz, M B A ^d   Latchman, D S ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Brn 3; Growth; Immunohistochemistry; Nav1.7; Real time PCR

Indexed keywords

COMPLEMENTARY DNA; RNA; SODIUM CHANNEL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRN 3A; TRANSCRIPTION FACTOR BRN 3C; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; GENE CONTROL; GENE OVEREXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MOLECULAR CLONING; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; HUMANS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHANNELS; TRANSCRIPTION FACTOR BRN-3A; TRANSCRIPTION FACTOR BRN-3C; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33644911768     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500837     Document Type: Article

References (54)

1. Francis NJ, Kingston RE. Mechanisms of transcriptional memory. Nat Rev Mol Cell Biol 2001; 2: 409-421.
2. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-629.
3. Harris H. Putting on the brakes. Nature 2004; 427: 201.
4. Latchman DS. POU family transcription factors in the nervous system. J Cell Physiol 1999; 179: 126-133.
5. Xiang M, Zhou L, Macke JP, Yoshioka T, Hendry SH, Eddy RL et al. The Brn-3 family of POU-domain factors: Primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci 1995; 15: 4762-4785.
6. Morris PJ, Dawson SJ, Wilson MC, Latchman DS. A single residue within the homeodomain of the Brn-3 POU family transcription factors determines whether they activate or repress the SNAP-25 promoter. Neuroreport 1997; 8: 2041-2045.
7. Budhram-Mahadeo V, Parker M, Latchman DS. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol 1998; 18: 1029-1041.
8. Budram-Mahadeo V, Morris PJ, Latchman DS. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1). Oncogene 2002; 21: 6123-6131.
9. Veenstra GJ, van der Vliet PC, Destree OH. POU domain transcription factors in embryonic development. Mol Biol Rep 1997; 24: 139-155.
10. McEvilly RJ, Rosenfeld MG. The role of POU domain proteins in the regulation of mammalian pituitary and nervous system development. Prog Nucleic Acid Res Mol Biol 1999; 63: 223-255.
11. Ndisdang D, Morris PJ, Chapman C, Ho L, Singer A, Latchman DS. The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions. J Clin Invest 1998; 101: 1887-1892.
12. Leblond-Francillard M, Picon A, Bertagna X, de Keyzer Y. High epression of the POU factor Brn3a in aggressive neuroendocrine tumors. J Clin Endocrinol Metab 1997; 82: 89-94.
13. Collum RG, Fisher PE, Datta M, Mellis S, Thiele C, Huebner K et al. A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system. Nucleic Acids Res 1992; 20: 4919-4925.
14. Lillycrop KA, Budeahan VS, Lakin ND, Tersenghi G, Wood JN, Polak JM et al. A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 1992; 20: 5093-5096.
15. Turner EE, Jenne KJ, Rosenfeld MG. Brn-3.2: A Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron 1994; 12: 205-218.
16. Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL, Latchman DS. The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene 1999; 18: 6684-6691.
17. Leonard JH, Bell JR. Insights into the Merkel cell phenotype from Merkel cell carcinoma cell lines. Australas J Dermatol 1997; 38 (Suppl 1): S91-S98.
18. Leonard JH, Cook AL, Van Gele M, Boyle GM, Inglis KJ, Speleman F et al. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma. Int J Cancer 2002; 101: 103-110.
19. Theil T, McLean-Hunter S, Zornig M, Moroy T. Mouse Brn-3 family of POU transcription factors: A new aminoterminal domain is crucial for the oncogenic activity of Brn-3a. Nucleic Acids Res 1993; 21: 5921-5929.
20. Theil T, Zechner U, Klett C, Adolph S, Moroy T. Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. Cytogenet Cell Genet 1994; 66: 267-271.
21. DeCarvalho AC, Cappendijk SL, Fadool JM. Developmental expression of the POU domain transcription factor Brn-3b (Pou4f2) in the lateral line and visual system of zebrafish. Dev Dyn 2004; 229: 869-876.
22. Budhram-Mahadeo V, Moore A, Morris PJ, Ward T, Weber B, Sassone-Corsi P et al. The closely related POU family transcription factors Brn-3a and Brn-3b are expressed in distinct cell types in the testis. Int J Biochem Cell Biol 2001; 33: 1027-1039.
23. Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. J Biol Chem 1998; 273: 16715-16722.
24. Budhram-Mahadeo V, Morris PJ, Lakin ND, Theil T, Ching GY, Lillycrop KA et al. Activation of the alpha-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J Biol Chem 1995; 270: 2853-2858.
25. Bostwick DG, Qian J, Pacelli A, Zincke H, Blute M, Bergstralh EJ et al. Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival. J Urol 2002; 168: 1204-1211.
26. Hansson J, Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Scand J Urol Nephrol 2003; 212 (Suppl): 28-36.
27. + channels in human prostate cancer cell lines and their contribution to invasiveness in vitro. Am J Pathol 1997; 150: 1213-1221.
28. + channel α-subunit genes in rat and human prostate cancer cell lines. The Prostate 2001; 48: 165-178.
29. Diss JKJ, Stewart D, Pani F, Foster CS, Walker MM, Patel A et al. A potential novel marker for human prostate cancer: Voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 2005; 8: 266-273.
30. Diss JKJ, Fraser SP, Walker MM, Patel A, Latchman DS et al. Beta subunits of voltage-gated sodium channel: Quantitative analyses of in vitro and in vivo expression in human prostate cancer. Prostate Cancer Prostatic Dis 2005 (submitted).
31. + channel expression to cell behaviours involved in the metastatic cascade in rat prostate cancer. I. Lateral motility. J Cell Physiol 2003; 195: 479-487.
32. Mycielska ME, Djamgoz MBA. Cellular mechanisms of direct-current electric field effects: Galvanotaxis and metastatic disease. J Cell Sci 2004; 117: 1631-1639.
33. + channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity. J Cell Physiol 2003; 195: 461-469.
34. Eng SR, Lanier J, Fedtsova N, Turner EE. Coordinated regulation of gene expression by Brn3a in developing sensory ganglia. Development 2004; 131: 3859-3870.
35. Kyprianou N, Bruckheimer EM, Guo Y. Cell proliferation and apoptosis in prostate cancer: Significance in disease progression and therapy. Histol Histopathol 2000; 15: 1211-1223.
36. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576.
37. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60: 7099-7105.
38. Berthon P, Dimitrov T, Stower M, Cussenot O, Maitland NJ. A microdissection approach to detect molecular markers during progression of prostate cancer. Br J Cancer 1995; 72: 946-951.
39. Bhargava AK, Li Z, Weissman SM. Differential expression of four members of the POU family of proteins in activated and phorbol 12-myristate 13-acetate-treated Jurkat T cells. Proc Natl Acad Sci USA 1993; 90: 10260-10264.
40. Corcoran NM, Costello AJ. Interleukin-6: Minor player or starring role in the development of hormone-refractory prostate cancer? BJU Int 2003; 91: 545-553.
41. Ndisang D, Budhram-Mahadeo V, Latchman DS. The Brn-3a transcription factor plays a critical role in regulating human papilloma virus gene expression and determining the growth characteristics of cervical cancer cells. J Biol Chem 1999; 274: 28521-28527.
42. Ndisang D, Budhram-Mahadeo V, Pedley B, Latchman DS. The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo. Oncogene 2001; 20: 4899-4903.
43. Schade SD, Brown CB. Identifying the promoter region of the human brain sodium channel subtype II gene (SCN2A). Mol Brain Res 2000; 81: 187-190.
44. Poiraud E, Gruszczynski C, Porteu A, Cambier H, Escurat M, Koulakoff A et al. The Na-G ion channel is transcribed from a single promoter controlled by distinct neuron- and schwann cell-specific DNA elements. J Neurochem 1999; 73: 2575-2585.
45. + channel gene expression. J Biol Chem 1998; 273: 11327-11334.
46. Sheng ZH, Zhang H, Barchi RL, Kallen RG. Molecular-cloning and functional-analysis of the promoter of rat skeletal-muscle voltage-sensitive sodium-channel subtype-2 (rskm2) - evidence for muscle-specific nuclear-protein binding to the core promoter. DNA Cell Biol 1994; 13: 9-23.
47. Yang P, Kupershmidt S, Roden DM. Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. Cardiovasc Res 2004; 61: 56-65.
48. Chong JHA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC et al. REST - a mammalian silencer protein that restricts sodium-channel gene-expression to neurons. Cell 1995; 80: 949-957.
49. Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF et al. Voltage-gated sodium channel expression and potentiaion of human breast cancer metastasis. Clin Can Res 2005; 11: 1-9.
50. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005; 121: 837-848.
51. + channel activity. FEBS Lett 2004; 569: 191-194.
52. Irshad S, Pedley RB, Anderson J, Latchman DS, Budhram-Mahadeo V. The Brn-3b transcription factor regulates the growth, behaviour and invasiveness of human neuroblastoma cells in vitro and in-vivo. J Biol Chem 2004; 279: 21617-21627.
53. Smith MD, Melton LA, Ensor EA, Packham G, Anderson P, Kinloch RA et al. Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro. Mol Cell Neurosci 2001; 17: 460-470.
54. Lee SA, Ndisang D, Patel C, Dennis JH, Faulkes DJ, D'Arrigo C et al. Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res 2005; 65: 3072-3080.